Pure red cell aplasia followed by disseminated intravascular coagulation in a haemodialysis patient receiving erythropoietin-beta.
Manenti
Lucio
L
Division of Nephrology and Dialysis, Desenzano del Garda Hospital, and Department of Clinical Medicine, Nephrology and Health Science, University of Parma, Italy. lucio.manenti@aod.it
Vaglio
Augusto
A
D000368:Aged; D000740:Anemia / Q000188:drug therapy / Q000209:etiology; D001172:Arthritis, Rheumatoid / Q000150:complications; D018450:Disease Progression; D004211:Disseminated Intravascular Coagulation / Q000139:chemically induced*; D004921:Erythropoietin / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007676:Kidney Failure, Chronic / Q000628:therapy; D008297:Male; D011994:Recombinant Proteins; D012010:Red-Cell Aplasia, Pure / Q000139:chemically induced*; D006435:Renal Dialysis / Q000009:adverse effects* / Q000379:methods
D011994:Recombinant Proteins; C103998:epoetin beta; D004921:Erythropoietin